The Prevalence of Urinary Tract Infections in Patients with Chronic Kidney Disease by Ravichandran, V
THE TAMILNADU Dr. M.G.R. MEDICAL UNIVERSITY, 
CHENNAI, TAMILNADU. 
 
 
 
 
 
 
 
THANJAVUR MEDICAL COLLEGE, THANJAVUR. 
 
 
 
DISSERTATION ON  
 
“ THE PREVALENCE OF URINARY TRACT 
INFECTIONS IN PATIENTS WITH CHRONIC  
KIDNEY DISEASE ” 
 
 
 
 
Submitted for M.D Degree Examination  
 
BRANCH – I 
( GENERAL MEDICINE )   
April 2011 
 
CERTIFICATE 
 
    This is to certify that the Dissertation entitled “THE 
PREVALENCE OF URINARY TRACT INFECTIONS IN 
PATIENTS WITH CHRONIC KIDNEY DISEASE” is a bonafide 
record of work done by Dr.V.RAVICHANDRAN in the department of 
Medicine, Thanjavur Medical College, Thanjavur, during his Post 
Graduate Course from 2008 to 2011. This is submitted as partial fulfillment 
for the requirement of M.D., Degree examinations – Branch –I (General 
Medicine) to be held in April 2011.  
 
  
 
Professor & Head,      M4, Unit Chief     
Department of General Medicine,   Department of General Medicine, 
Thanjavur Medical College,     Thanjavur Medical College, 
Thanjavur.       Thanjavur. 
 
    
 
The Dean, 
Thanjavur Medical College, 
Thanjavur. 
 DECLARATION 
 
 
 I, Dr. V.RAVICHANDRAN, solemnly declare that the dissertation 
titled “THE PREVALENCE OF URINARY TRACT INFECTIONS IN 
PATIENTS WITH CHRONIC KIDNEY DISEASE” is a bonafide work 
done by me at Thanjavur Medical College Hospital, Thanjavur, during  
Dec 2009 – Nov 2010. 
 The dissertation is submitted to “The Tamilnadu Dr. M.G.R. 
Medical University, Chennai”, Tamilnadu as a partial fulfillment for the 
requirement of M.D Degree examinations – Branch –I (General Medicine) 
to be held in April 2011.  
 
 
 
 
Place: Thanjavur 
Date:  
       
 
 
(Dr. V.RAVICHANDRAN) 
       
ACKNOWLEDGEMENT 
 
I am extremely grateful to the Dean Dr. P. RAVISHANKAR M.D, 
D.H.A., Thanjavur Medical College for granting me permission to do this 
dissertation in the Thanjavur Medical College Hospital, Thanjavur. 
  
I am very grateful to our Professor and Head of the Department of 
Medicine Prof. S.MUTHUKUMARAN M.D., for his valuable 
suggestions in preparing this dissertation.  
 
I am deeply indebted  to my unit Chief Prof. Dr. V. RAJENDRAN 
M.D, for his invaluable guidance, perspectives, assortment of emerging 
views, compiled with patience and constructive criticisms throughout the 
gestation period has made this seemingly Juvenile attempt a worthy, 
Informative and lucid contribution. 
 
My humble gratitude  in abundance to Prof. Dr. T. RAJENDRAN 
M.D., D.M., (Nephro) Asst. Professor of Nephrology for being the role 
guiding  force in the practical execution of this project. 
 
I am extremely thankful to Prof.Dr.LOGESWARI SELVARAJ 
M.D, (Micro),  Prof. and HOD, Department of Micro Biology for her 
valuable suggestions and guidance. 
 I recall with gratitude unit chiefs of department of medicine Prof. Dr. 
P.KRISHNAMOORTHY M.D., Prof. Dr. P.G.SANGARANARAYANAN 
M.D., Prof Dr. K.NAGARAJAN M.D., and Prof Dr. K.PARIMALA DEVI 
M.D., for having permitted me to work on their patients in their respective 
units. 
 
I am extremely thankful to Dr.C.PARANDHAKAN M.D., 
Dr.C.GANESAN M.D., Dr. G.GOWTHAMAN M.D., and other 
Assistant professors of Medicine for their guidance throughout the study.
  
 
I also thank our patients without whom the study would not be 
possible. 
I owe my thanks to the almighty for successful completion of the study.   
 
 CONTENTS 
 
S.NO TITLE PAGE NO. 
1. INTRODUCTION 1 
2. AIMS AND OBJECTIVES  3 
3. REVIEW OF LITERATURE 4 
4. MATERIALS AND METHODS 42 
5. OBSERVATION AND RESULTS 46 
6. ANALYSIS AND DISCUSSION 54 
7. CONCLUSION 60 
8. BIBLIOGRAPHY  
9. MASTER CHART  
 
INTRODUCTION 
 
 Urinary tract infection is the most common of all bacterial infections 
affecting humans through out their life span. The estimated incidence of 
urinary tract infection in developed countries is as high as 8 -10 million per 
year. 36.3% in hospitalised patients and 16.5% in non-hospitalised patients. 
Urinary tract infections are the leading cause A gram negative sepsis in 
hospitalised patients
1
.  
 
 The incidence of urinary tract infection is influenced by age, sex and 
by predisposing factors that impair the defence mechanisms that maintain 
the sterility of urinary tract. 
 
 In chronic kidney disease dysfunction of the host defences is one of 
the major functional disturbances and result in increased susceptibility to 
various infections
2
. Besides urosepsis and septicemia they result in further 
deterioration of metabolic profile in these patients. Although potentially 
curable, the diagnosis is often difficult as many of the distinguishing 
features of infection may be absent in renal failure. The functional 
impairment of polymorphonuclear cells, impairment of cell mediated and 
humoral immunity, malnutrition and dialysis procedure may contribute to 
the impaired immune function resulting in increased preponderance of 
infections in patients with chronic kidney disease
61
. Although any part of 
the body may be the focus of infection, urinary tract may act as a nidus of 
infection in many of chronic kidney disease patients. Infection of urinary 
tract may be a part of infection of renal parenchyma such as chronic 
pyelonephritis or due to secondary structural abnormality in urinary tract, 
obstructive uropathy, use of immunosuppressive agents, diabetes mellitus 
or catheterization. The contribution of uraemia in urinary tract infection is 
not known. 
 
 The present study was designed to prospectively assess whether 
uraemia or severity of chronic kidney disease per se in the absence of 
various predisposing factors results in higher incidence of urinary tract 
infection. In this study we compared the degree of leucocyturia and urinary 
tract infection in patients with chronic kidney disease and healthy 
population. 
 
 
 
 
 
 
 
  
AIMS AND OBJECTIVES 
 
1. To compare the incidence of UTI in chronic kidney disease patients 
and control population. 
2. Age and sex distribution of urinary tract infection in chronic kidney 
disease patients and control population. 
3. To map out the relationship between urinary tract infection and 
severity of chronic kidney disease. 
4. Identification of uropathogens responsible for urinary tract infection 
in chronic kidney disease patients and control population. 
 
 
 
 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
 
HISTORICAL REVIEW 
 Individual cases of urinary tract infection were recorded in antiquity. 
For example, according to Asscher, there is little doubt that the reference to 
‘sending forth heat from bladder’ in Egyptian papyri must have indicated 
the presence of infection. In Britain the first report of urinary tract infection 
appears to have been in 1412 by John of Ardenne. 
 
 Pasteur (1863) recognized urine as a good culture media for bacteria 
and Roberts (1881)
3
 related the presence of bacteria in the urine to 
symptoms, but very little progress was made in exploring this relationship 
until quantitative assessments of the number of bacteria in the urine of 
patients with urinary tract infection were carried out by Marple(1941)
4
 Barr 
and Rantz (1948)
5 
and Sanford etal (1956)
6
.  
 
A comparison of catheter and Voided Specimens of urine allowed a 
distinction to be made between contamination with urethral or perineal 
bacteria (usually with gram positive cocci) and true infection of the bladder 
(usually with gram negative bacilli) Kass (1960)
7
 Pfau and sacks (1970)
8
. 
Careful preparation of periurethral area before catheterization resulted in a 
lower rate of contamination. Quantitative bacterial counting in both 
selected and unselected groups of the population showed that when the 
urine contained over 10
5
 bacteriae/ml this could be regarded as true or 
significant bacteriuria (Kass 1955, 1956, 1957)
7
. Most patients with 
chemical infection had counts of 10
5
 organisms per ml but even when there 
were no symptoms a few patients had bacterial counts of this magnitude. 
Thus the concept of symptomatic bacteriuria was established. Its 
association with the development of clinical infection and renal damage is 
well recognized. 
 
Following World War II, several studies were conducted to study the 
exact relationship between renal failure and infection. Infection in the 
presence of other urinary tract lesions such as vesicoureteric reflux, 
calculus or analgesic abuse could accelerate the development of renal 
damage
9
. Reports began to appear suggesting that infection was a frequent 
complication of renal failure. (Bull and Merill)
10
 stated that patients with 
renal failure were susceptible to infections.  
 
PATHOGENESIS AND EPIDEMIOLOGY OF UTI: 
 Urine is normally a sterile body fluid. Presence of bacteria 
(bacteriuria) fungi (fungiuria) or virus is defined as infection. The term 
does not imply the presence or absence of associated symptoms. 
Acute infections of the urinary tract based on anatomic categories. 
  Lower UTI – Urethritis and cystitis 
           Upper UTI – Acute pyelonephritis, Prostatitis, intrarenal and 
perinephric   abscess           
 
Chronic pyelonephritis refers to chronic interstitial nephritis from 
bacterial    infection of the Kidney. 
 
Epidemiologically UTI’s are divided into catheter associated 
(Nosocomial) or non Catheter associated (Community acquired). Infections 
of either category may be symptomatic or asymptomatic. 
 
UTI are unusual in male patients under the age of 50. Symptomatic 
infection is common among women between 20 and 50. Asymptomatic 
Bacteriuria is more common among elderly men and women. 
      UTI in adults can be categorized into six groups
12 
1. Acute uncomplicated cystitis in young women. 
2. Recurrent acute uncomplicated cystitis in Young women. 
3. Acute Uncomplicated pyelonephritis in young women. 
4. Acute uncomplicated cystitis in adults with the following condition. 
 Male Sex 
 Elderly 
 Pregnancy 
 Recent urinary tract instrumentation 
 Childhood UTI 
 Recent Antimicrobial use. 
 Symptoms > 7 Days 
 DM. 
 
5) Complicated UTI
13 
a) Obstruction – Urolithiasis, Ureteric and urethral stricture, 
bladder diverticulas or Malignancy, urinary diversions. 
b) Foreign bodies – indwelling catheter, ureteral stent, 
Nephrostomy tube 
c) Functional abnormality – Neurogenic bladder, Vesicoureteric 
Reflux. 
d) Others – RENAL FAILURE, Renal transplantation, 
Immunosuppression, Multidrug resistant, Uropathogen, 
Prostatitis related infection. 
6) Asymptomatic Bacteriuria 
  
Distinction between uncomplicated and complicated UTI is 
important mainly because of the necessity of evaluation of urinary tract and 
type and duration of antimicrobial treatment varies. Asymptomatic 
Bacteriuria in patients with complicated UTI like Renal failure, renal 
transplant, obstruction or neutropenia should require treatment.  
 Seven days of therapy with oral agents to which the organism is 
sensitive should be given. Long term therapy (4-6 weeks) may be 
necessary in high risk patients with persistent asymptomatic Bacteriuria. 
Asymptomatic Bacteriuria in immunosuppressive patients run an increased 
risk of bacteremia and hence it needs to be treated (MN Acharya etal)
13 
 
ETIOLOGY:  
          Most common agents are gramnegative bacilli Escherichia coli is by 
far the most frequent, cause of uncomplicated community acquired UTI’S11         
 
 
 
                                                                   
Organism Uncomplicated Complicated
12
 
 Route of infection: 
 Bacteria can invade and cause UTI via two major routes. Ascending 
and Hematogenous pathways. 
 
G-Ve Organisms  
 E-Coli 70-95 21-54 
 Proteus mirabilis 1-2 1-10 
 Klebsiella  1-2 1-17 
 Pseudomonas < 1 2-19 
 Citrobacter  < 1 5 
 Enterobacter  < 1 2-10 
Gram +ve organisms:   
 Staph 
Saprophyticus 
5-20 1-4 
 Enterococci 1-2 1-23 
 Group B 
Streptococci 
< 1 1-14 
  Staph aureus < 1 1-2 
 Ascending infection is the most common route of infection in 
females.  Ascent in association with urinary catheterization or cystoscopy 
is the most common cause of hospital acquired UTIS in both the sexes.  
 
The high prevalence in females is because of short urethra (4 cm), 
close proximity to anus and its termination beneath the labia. Sexual 
intercourse causes introduction of bacteria into the bladder. Honey moon 
cystitis being a well recognized clinical entity in females. The relative 
infrequency of UTI in men may be attributed to the length of male urethra 
and bactericidal activity of prostatic fluid. The recurrent urinary symptoms 
in young and middle aged men may probably linked to prostatic 
dysfunction and in elderly male prostatic hypertrophy and changes in the 
residual volume of the bladder with reduced urineflow. Uterine prolapse 
increased the infection in elderly Women. With insertion of a urinary 
catheter the bacteria may be pushed along the urethra into the bladder or 
migrate along the track between the catheter and the urethral mucosa, 
gaining access to the bladder. Hematogenous spread (Descending Route) 
usually occurs as a result of baceteremia. Staphylococcus aureus or 
salmonella sp., candida albicans, Mycobaterium tuberculosis, leptospira 
sp., are common organisms. 
 
 
PREDISPOSING FACTORS: 
Obstruction to the flow of urine by anatomical or pathological 
abnormalities are major predisposing factors at any age. 
 
SUGGESTED PRECIPITATING FACTORS IN THE DEVELOPMENT OF 
UTI 
ANATOMICAL                              CONGENITAL ABNORMALITIES 
                                                         PROSTATIC HYPERTROPHY 
                                                         CYSTOCELE, UTERINE PROLAPSE 
                                                         VUR. 
PATHOLOGICAL                          SURGICAL OPERATIONS ON THE 
                                                         UROGENITAL TRACT, TUMOURS 
                                                         OF BLADDER AND PROSTATE 
                                                         URETHRAL CATHETERIZATION 
                                                         SYSTEMIC ILLNESS – CKD, DM, 
                                                         ATROPHIC VAGINITIS 
                                                         NEUROLOGICAL DISORDERS OF 
                                                         BLADDER, IMMUNO SUPPRESSION. 
INFECTIVE                                    VULVOVAGINITIS 
                                                         VAGINAL DISCHARGE 
SOCIAL                                           SEXUAL INTERCOURSE 
                                                         MENSTRUATION 
ENVIRONMENTAL                      SEDENTARY OCCUPATION 
 
Bacterial virulence: 
Not all strains of E.coli are equally capable of infecting the intact urinary 
tract. Uropathogenic E-coli have 
- Type 1fimbria that binds to uroepithelial cells  
- Type P fimbriae 
- ,  Hemolysins, cytotoxins that lyse erythrocyte capsule 
- Siderophore for scavenging iron. 
Geneticfactors: Maternal History of UTI are often found among women 
who had recurrent UTI. 
 
MULTIPLICATION  OF BACTERIA IN URINE 
In the urinary tract there is a dynamic culture system in which 
bacteria undergo multiplication while urine is continuously being added by 
glomerular filtration and lost by micturition. 
 
Normal urine unlike other body fluids does not contain significant 
quantities of lysozyme or immunoglobulin. Increased concentration of Ig 
A, IgG and IgM (Kaufman et al 1970)
14
 (Burdon et al)
15 
are found in adults 
with UTI. Phagocytosis of bacteria is impaired both by the absence of 
opsonin and the wide range of osmolality in urine (Chernew and Braude 
1962)
16
. These considerations apply to urine alone, because mucosal 
defense mechanisms are highly active throughout the urinary tract.
 
 
The ability of urine to support bacterial growth is related to urinary 
PH, osmolality and chemical constituents such as glucose, amino acids and 
organic acids. Optimal bacterial growth occurs within a PH range of 6-7. 
Outside this range growth is either slowed or inhibited. The osmolality of 
the urine is an index of the concentrating ability of the Kidney. A lowered 
osmolality encourages bacteriuria (Winverg 1959)
17
(Katiz 1961)
18
; this is 
probably due to the associated presence of intrarenal infection, because 
eradication of this has been shown to correct the impairment of urinary 
concentrating ability (Norden and Tuttle 1965)
19
. 
   
Glucose provides a source of energy for the growth of  urinary 
pathogenic bacteria and under experimental conditions prolongs the 
logarithmic phase of growth. The number of bacteria in the urine of 
diabetic patients was significantly higher than in that of non-diabetic 
controls (O’ Sullivan et al 1961)20 .Competitors of glucose utilization, 
2deoxy –D.glucose and 6deoxy – D. glucose, reduce bacterial counts in 
urine (Weiser et al )
21
. Normal urine usually contains sufficient glucose to 
support maximal growth rates and any lowering of the PH is prevented by 
its buffering capacity. 
 
The amino acid combination of urine may vary considerably; effects 
on bacterial growth have been noted. (Rooberts et al 1968)
22
, but it is 
unlikely that these are important in urinary tract infection. Organic acids 
are also normally present in urine and may be bacteriostatic according to 
the degree of this dissociation. Urea in high concentration was shown to be 
bactericidal against urinary-tract pathogens (Schlegel et al 1961)
23
, but it is 
likely that is effect is mainly due to an increase in osmolality because 
bacterial inhibition also resulted from the addition of salts to give 
hyperosmolality. 
 
DEFENSE MECHANISMS 
            Protection of the urinary tract against infections strongly related to 
the constant flow of urine and regular emptying of the bladder. Reduction 
in the regular flow of urine by for example, bladder-neck obstruction, 
prostatic hypertrophy or neurological disorders of bladder favors an 
increase in the number of bacteria and the development of infections. The 
efficiency of this hydrokinetic defense mechanism will depend on a 
balance of factors such as growth rate, the frequency of micturition, the 
urine flow from the kidneys, the residual volume of the bladder and the 
chemical composition of the urine and its ability to support bacterial 
growth. 
 
The presence of Valvular structures in the urinary tract prevents or 
hinders the ascent of bacteria by reflux of urine. The uretero vesical valve 
is competent from both urine and bacteia by virtue of muscular structures 
(Tanago and Pugh 1963)
25
 (Hutch 1972)
26
 that permit a constant flow of 
urine from the ureter into the bladder (Stephens and Lenaghan 1962)
27
  but 
prevent reflux when the bladder is full or during  micturition . Any change 
that impairs the integrity of this musculature may result in a retrograde 
flow of urine and leads to persistence of the infection by producing a 
ureteral residue (Edwards 1968)
28
. Complete emptying of the bladder tends 
to prevent infection, an excess of residual urine is commonly found in 
patients with recurrent infection (Hunman and Baumann 1973)
29
,( Allen 
1977)
30
. The urethro vesical valve is fluid competent but does not prevent 
the upward passage of bacteria into the bladder. They pass more easily up 
the female than up the longer male urethra and abnormal urodynamics may 
be more important in women than in man as a cause of recurrent infection 
(Lapides 1974)
31
. 
 
Mucosal defence against infection may result either from the 
phagocytic properties of inflammatory cells or from the secretion by 
mucosal cells of substances that inhibit the adhesion of bacteria or kill 
them (Vivaldi et al 1965)
32
. The urine contains many types of antibodies 
(Immunoglobulins) and these are considerably increased in amount when 
infection occurs in the tract. They may have protective role in the renal 
tissue, but in the urine no antibacterial activity has been established (Kaye 
1968)
33
. An immune response occurs in adults and children with renal 
infection, as demonstrated by the production of serum antibodies to the 
somatic antigens of strains of E.Coli (Needell et al 1955)
34
, (Pervical et al 
1964)
35
 , although (Wineberg et al 1963)
36
 found a response only in 
association with lowered concentrating ability.  These antibodies were 
strain specific and would be of potential value only in recurrent infections 
due to the same strain. The various components of complements are either 
absent from urine or are inactivated by it (Beeson and Rowley 1959)
37
. 
Studies in experimental animals have supported a role for immunity in 
both renal and bladder infection (Arana et al 1965)
38
. Lehman et al 
1968)
39
, but immunization with somatic antigens to be specific virulence 
factors (Glyn et al 1971)
40
 it gave only incomplete protection (Radford et 
al 1974)
41 
 
Prostatic secretions have been reported to have antibacterial activity 
in men. (stumey et al 1968)
42
. The antibacterial factor had shown to be 
zinc (fair et al 1976)
43
. Prostatic fluid zinc levels were considerably lower 
in men with chronic bacterial prostatitis than in normal men. 
 
Significance of Bacteriuria: 
In most patients growth of > 10
5
 organisms or colony forming units 
(CFU) per ml from a properly collected mid stream clean catch urine 
sample indicated significant bacteriuria. 
In symptomatic patients, suprapubic aspiration or sample collected 
from indwelling catcheter colony counts of 10
2
-10
4
/ml generally indicate 
infection. 
 
In Asymptomatic patients two consecutive urine specimens with 
colony counts of > 10
5
 bacteria of single species per ml should be 
demonstrable in both the specimens before initiating therapy. In 
complicated UTI colony count threshold of >10
3
 CFU/ml is used to 
diagnose infection as per Infections Disease society of America consensus; 
but concomitant significant pyuria (Presence of 8 or more leucocytes per 
cubic mm on microscopic exam of uncentrifuged urine) should be present. 
 
CHRONIC KIDNEY DISEASE: 
 
It is defined as either Kidney damage or Glomerular filtration rate 
<60 ml/mt/1.73 m
2
 for 3 or more months. Kidney damage is defined as 
pathologic abnormalities or markers of damage including abnormalities in 
blood, urine tests or imaging studies
45
. 
 
The National Kidney foundation (Kidney dialysis outcomes quality 
intitative   KDOQI) provides stages of chronic Kidney disease according 
to  estimated GFR
45
.  
 
STAGE DESCRIPTION 
GFR 
(ml/mt/1.73m
2
) 
ACTION 
I Kidney damage > 90 Diagnosis, 
with normal or 
GFR 
treatment, 
cardiovascular 
disease-risk 
reduction 
II 
Kidney damage 
with mildly GFR 
60-89 
Estimate 
progression 
III Moderately GFR 30-59 
Evaluate and treat 
complication 
IV Severely ↓GFR 15-29 
Prepare for Renal 
Replacement 
therapy (RRT) 
V Kidney failure 
< 15 
Or 
Dialysis 
RRT 
V 
Uraemic 
Emergency  or 
ESRD 
< 5 
hyperkalemia, pulm 
edema, pericarditis 
Encephalopathy 
warrants emergency 
Dialysis.. 
 
The term chronic renal failure applies to the process of continuing 
significant irreversible reduction in nephron number and corresponds to 
CKD stage 3-5 .The term End stage Renal Disease (ESRD) represents a 
stage where the accumulation of toxins, fluid and electrolytes normally 
excreted by the Kidneys result in the uraemic syndrome. It corresponds to 
stage 5 with uraemic emergencies.  
 Glomerular Filtration Rate (GFR)
46 
Two Equations are commonly used to estimate GFR, Using serum 
creatinine Age, sex, race and Body weight. 
The normal annual mean decline in GFR with age from the peak GFR 
(120 ml/mt/1.73 m
2
) starts from the 3rd decade. It reaches a mean value of 
70 ml/mt at 70 yrs.  The mean GFR is lower in women than men. 
 
1. Cockcroft – Gault Equation: 
               Estimated GFR (ml/mt) 
                                            = (140 – age) X Body wt in Kg  
                                                __________________________ 
                                                     72x serum creatinine (mg/dl) 
                                                     Multiply by 0.85 for women. 
 
 
 
2. Modification of Diet in Renal Disease study Formula. (MDRD) 
                       GFR = 1.86 X (Plasma creatinine)
 -1.154
 X (AGE) 
-0.203
 
                       Multiply by 0.742 for women 
                       Multiply by 1.21 for African Americans. 
We adopt cockcroft Gault formula to estimate GFR in this study. 
 
Minimising Progression in CKD: 
Delaying or preventing progression of kidney failure is a priority in 
the Management of any CKD patients. 
 
Some of the causes for acute on CKD: 
1. Infection. 
2. Dehydration 
3. Nephrotoxic drugs- NSAIDS, ACEI, ARB etc. 
4. Accelerated Hypertension 
5. Urinary tract obstruction. 
6. Heart failure, Hypotension – compromise renal perfusion 
 
Morbidity and mortality remain high in Patients with CKD 
predominantly due to infections and cardiovascular complications. The 
incidence rate of sepsis, urinary tract infection (UTI) and pneumonia in 
patients with and without CKD were reported from medicare patients in 
1998 by Anne murrray MD. Of minneapolis minnesota
47
.  Most patients 
had stage 3 CKD. There was 2-3 fold increased risk of sepsis UTI and 
pneumonia in patients with CKD. The mortality rate in CKD patients with 
one of these infections was 1.5-2 times greater in CKD patients compared 
with non CKD patients. The rates of bacteremia or UTI were similar in HD 
and PD patients.  
 URINARY TRACT INFECTION IN CKD  
Patients with CKD have an increased susceptibility to infection. 
Septicemia is commonly a complication of UTI in CKD. The same 
organism can be cultured from urine and blood
48
. The urinary tract 
constitutes a frequent source of infection in these patients. Multiple factors 
may be responsible for the increased incidence of UTI such as suppression 
of various aspects of immune system, azotemia, infrequent voiding, low 
urinary flow rate and urinary concentration defects. 
 
MECHANISMS RESPONSIBLE FOR INFECTION IN CKD 
A number of separate mechanisms of host defence may be impaired 
in renal failure. 
 
 
 
1. HOST DEFENSES IN RENAL FAILURE 
It is difficult to discuss susceptibility of the host except in terms of a 
specific parasite. The approach to this problem is a description of an 
infectious disease by its location stresses the importance of alternation of 
the local defence mechanisms which increases susceptibility to infection in 
renal failure.  
 A. LOCAL BARRIERS TO INFECTION 
  Intact skin and mucous membrane are frequently damaged in 
patients with renal failure. The alternation of natural barriers, trauma to 
skin and mucous membrane has part of the natural history of renal failure. 
Urinary catheterization and other measures repeatedly break mucosal 
barriers.  Each of this manoeuvers is a potential threat to the patient. 
 
B. INFLAMMATORY RESPONSE AND PHAGOCYTOSIS 
Limited evidence suggests that the host is incapable of a normal 
inflammatory reaction in renal failure (Blach and Evans). A lesser 
inflammatory response to infection of monosodium urate in patients with 
CKD was noted by (Buchman et al )
49
. 
 
Renal failure may influence different aspects of inflammatory 
response eg; migration of granulocyte was found to be reduced in patients 
with renal failure and acidosis. A direct metabolic effect of acidosis on 
granulocyte may be responsible since similar effect and other altered 
granulocyte function were seen in diabetic patients with DKA. The 
influence of osmolality could interfere with the actions of phagocytes. 
Increased osmolality of the suspending solution inhibited phagocytosis and 
intracellular killing of bacteria in vitro.  
 Leukocytes pyrogen probably plays an important role in local 
inflammation and also in systemic response to infection. Potassium has 
been shown to influence the release of pyrogen & it is possible to speculate 
that raised K level or other blood electrolyte changes alter the fever and 
inflammatory response in renal failure by these means. 
 
C. IMMUNE MECHANISM 
HUMORAL: A clinical study has demonstrated that humoral antibody 
production may be impaired in CKD. Wilson et al
50
 measured the response 
to typhoid vaccine in 10 patients with CKD and 22 normal subjects. 
Patients with renal failure had a reduced reponse to O & H antigen. Other 
components of serum concerned with immune mechanism have been 
examined in renal failure. Serum complement levels and alpha globulin 
have been found to be normal in patients with CKD although reduced 
properdin levels have been noted. 
CELLULAR:  Experiments in recent clinical trials have been shown a 
suppression of cell mediated delayed hypersensitivity reaction in CKD, 
The mechanism of prolonged survival of homograft in renal failure aptly 
called nature’s immunosuppressive device by Lawrence has been long 
studied. There is evidence which suggests that the reaction of lymphoid 
tissue is altered in renal failure. (Burewell et al )
51 
 Changes in lymph nodes were noted in patients with CKD by 
mutirhead & Shields
52
 Black and Chaborn
53
 found that axillary lymph 
nodes from 34 patients with renal failure showed dilated sinusoids that 
contain erythrophagocytic histiocyte in loose syncitial arrangements. 
Plasma cells, eosinophils and Secondary follicles were typically absent in 
these lymph nodes when compared with control subjects. The absence of 
secondary follicles suggested that there was an impaired responsiveness of 
the lymph nodes of patients with CKD Black and Chaborn
53
 commented 
that this was particularly notable because many of these patients died with 
intercurrent infection when secondary follicles should have been prominent 
in lymph nodes. Wilson et al also noted that thymus gland removed from 
subjects with renal failure were atrophic. He also suggested that there was 
impairment in the formation of cells containing cell bound antibody (or 
cells forming humoral antibody). Lymphopenia in renal failure adds other 
evidence of altered lymphoid tissue. 
 
II. FACTORS RESPONSIBLE FOR ALTERED HOST DEFENCES 
A. TOXIC AGENTS: 
Many substances excreted in urine and which accumulates in the 
body in renal failure (Phenol, indole, aromatic acids) has been shown to 
have profound effects. Serum from patients with renal failure was found to 
inhibit serum enzymes in vitro and similarly (Hicks et al )
54
 showed that 
many aromatic acids that accumulate in CKD depress the reaction rate of 
enzymes. (Marksin & Rewice)
55
 noted that that maturation of normoblastin 
tissure cultures of bone marrow was inhibited by uraemic serum. Protein 
synthesis was inhibited by uremic serum. Protein synthesis was inhibited 
by compounds isolated from patients with CKD. Urea has also been shown 
to interface with Antigen Antibody reaction. Although the concentration of 
urea required producing these effects are usually considerably in excess of 
those found in renal failure. It has been found that urea in concentration as 
low as 0.05 M inhibits Monoamine oxidase. 
 
B. ACIDOSIS 
Dubos who formulated the hypothesis that factors activating 
infections operate through common pathways, stressed the significance of 
metabolic state in host parasite equilibrium. 
 
   The importance of H+ ion concentration in acute inflammation, the 
action of reticulo endothelium system, bacterial proliferation and the 
antimicrobial activity of tissues. Metabolic acidosis has usually impaired 
host defenses in studies conducted. The delayed appearance of leucocytes 
at an inflammatory site and the impaired phagocytic function have been 
described in patients with renal failure and diabetes mellitus. Shreiner & 
Mahar
56 
Speculate about the possibility that intracellular K
+
 deficiencies 
occurring as a result of renal failure may account for an increased 
susceptibility to infection. The histological changes in renal tubules that 
follow this increased the susceptibility to pyelonephritis.   Change in PH 
influences the bactericidal action of serum. Chronic acidosis also may 
result in reduced collagen formation and poor wound healing thus 
perpetuating infection, thus in patients where the PH of inflammatory 
exudates is considerably less as such when compared to blood, further 
lowering of PH may be an important determinant in the host- parasite 
relationship in renal failure. 
 
C. MALNUTRITION 
Patients in chronic Kidney Disease are usually undernourished as a 
result of nausea, vomiting and unattractive lowprotein diets. It is difficult 
to correlate resistance of infection with malnutrition. Although increased 
susceptibility to infection in children with Nephrotic syndrome is well 
recognized and has been assumed to result from low levels of serum 
gamma globulin, it is not clear whether the degree of protein deficiency in 
CKD which is insufficient to alter measurable protein levels in the blood 
can account for increased susceptibility to infection. 
 
D. CORTICOSTEROIDS 
The striking similarities between effects of renal failure and the 
action corticosteroids has led to the speculation that failure may produce 
some effect like prolonged homograft survival, reduced fever reaction and 
inhibition of protein synthesis. Elevated levels of 17 hydro corticosteroid 
often reported in patients with chronic kidney Disease appears to depend 
mainly on the reduced clearance by the damaged kidney and the changes 
are reversible. These elevated 17 hydroxy corticosteroids may play a role 
in increased susceptibility to infection. 
 
DIAGNOSIS OF UTI 
SYMPTOMATOLOGY AND CLINICAL FORMS OF UTI 
 Symptoms of lower urinary tract infection include dysuria 
frequency&urgency, strangury, hematuria and suprapubic pain, but in 
many patients significant baceriuria may be present without symptoms. 
Diagnosis based on symptoms alone is highly inaccurate with a 50% of 
false negative rate. 
Definitions of some of the urinary symptoms: 
Dysuria – Pain immediately before, during or after micturition. 
Urgency- Loss of normal ability to postpone micturition. 
Frequency- Frequent voiding results from reduction of functional bladder 
capacity or bladder and urethra irritation. 
Strangury: Unpleasant and painful desire to void when the bladder is empty 
or nearly so. 
 
Clinical forms of urinary tract infection: 
1.Cystitis: 
Usually report dysuria, frequency, urgency and suprapubic pain. 
Urine is cloudy and malodorous or bloody. physical examination 
reveals tenderness over suprapubic area. 
 
2. Acute urethral syndrome: 
Patients are young, sexually active women, Dysuria, frequency or 
urgency with colony counts, 10
5
 cfu/ml in urinary culture. Chlamydia, N. 
Gonorrhoeae, or anaerobic infections account for some cases. 
 
3. Acute Pyelonephritis: 
Fever, chills, rigor, abdominal pain, nausea, vomiting or diarrhoea 
may be present. 
Physical examination reveals tenderness on deep pressure over one 
or both. Costovertebral angle. 
Persistence of fever or symptoms beyond 72 hrs after appropriate 
antibiotics warrants urological imaging 
 
4. Infection associated with bladder dysfunction 
 Neurological disorders of spinal cord, multiple sclerosis or CVA, 
malignancy of bladder and prostate and disturbances following surgical 
procedures also may affect the urine flow and often necessitate 
catheterization. Often specimen collection is difficult and organisms 
present frequently show multiple drug resistance. Bacteriuria should 
always be confirmed but treatment should be considered, only when there 
are constitutional symptoms or difficulty in maintaining freedrainage. 
Intravesical wash out with antiseptic or antimicrobial agents may be the 
best treatment. 
 
5. Infection in diabetics 
UTI is 2-3 times more common in adult diabetic patients than in non 
diabetics. Failure to control blood sugar may be contributory factor and this 
group is particularly predisposed to develop acute pyelonephritis and renal 
papillary necrosis. Bacterial counts tend to be high in diabetic urine 
because of increased glucose content. 
 
Emphysematous pyelonephritis: 
 It occurs almost, always in diabetic patients. It is characterised by a 
rapid progressive course with high fever, leucocytosis, and renal 
parenchymal necrosis accumulation of fermentative gases in the kidney 
and perinephric tissues. Most patients have significant pyuria. E coli cause 
most cases. Enterobactericeae causes some cases. Gas is seen on plain 
films but confirmed by CT scan. Appropriate antibiotics with surgical 
resection of the involved tissue are warranted. It carries high mortality. 
 
6. Bacteriuria of pregnancy     
 The prevalence of bacteriuria in pregnant women may rise to 10% at 
term. Increase in parity and a past history of UTI significantly increases the 
likelihood of bacteriuria. Prematurity, low birth weight and fetal mortality 
appear to be increased reflecting past or recurrent UTI, current renal 
abnormalities or diseases. The association of acute pyelonephritis together 
with other risk factors justifies urinary screening for antenatal bacteriuria. 
 
 
 
 
7. Bacterial prostatitis: 
 In young men, prostatic infection causes frequency, dysuria, perineal 
or testicular pain and in acute cases myalgia and fever. If prostatic fluid is 
available a microscopical and bacteriological culture can be carried out. 
The diagnosis is best made by the stamey test. In all cases significant 
bacteriuria may be present. Though in chronic infection the count is low 
but significant eradication is difficult due to difficult penetration by anti 
microbial into prostate. 
 
8. Others 
Genito urinary TB - The presence of persistent sterile pyuria and culture 
of TB bacilli offers diagnosis.  
Viruses are not very common as causative agents. Fungal infections 
are important in immunocompromised. Parasitic infections of the urinary 
tract may led to various pathological lesion.                                  Eg: 
Schistosomiasis, Trypanosomiasis, Filariasis & Hydatid disease. 
 
 
 
 
 
CRITERIA FOR CLASSIFICATION OF UTI: 
 
S.No Category Clinical Laboratory 
1. 
Acute 
Uncomplicated 
UTI in women 
Dysuria, urgency 
frequency, suprapubic pain 
no fever or flank pain 
> 10 WBC / mm3 
> 10
3 
CFU /ml of 
uropathogens in 
mid stream clean 
catch urine.   
2. 
Acute 
Uncomplicated 
pyelonephritis 
Fever with chills, flank 
pain 
> 10 WBC /mm3 
> 10
4
 CFU /ml of 
uropathogen in mid 
stream clean catch 
urine. 
3. 
Complicated UTI 
and UTI in men 
Any combination of 
symptoms 
Factors associated with 
complicated UTI. 
> 10 WBC/mm3 
> 10
5
 CFU /ml of 
uropathogen in mid 
stream clear catch 
urine. 
4. 
Asymptomatic 
bacteriuria 
No urinary symptoms 
> 10 WBC /mm3 
> 10
5
 CFU /ml in 
two consecutive 
mid stream clean 
catch urine > 24 hrs 
apart. 
 
 
 
SPECIMEN COLLECTION 
 Various methods may be used for the collection of urine specimen. 
Volume of urine collected varies depending upon the suspected pathogens 
and kind of processing necessary for isolation. The minimal acceptable 
volume when bacterial pathogens are suspected is about 0.5 to 1 ml. 
However at least 3 ml must be collected preferably. 
 
Methods used to collect urine specimen 
 Suprapubic aspiration 
 Mid stream clean void 
 Midstream void 
 Uncleansed initial – void 
 In and out (or straight) catheterization. 
 Use of indwelling catheter. 
 Use of suprapubic catheter. 
 Use of external collection device. 
 Use of ileal conduit. 
 Cystoscopy. 
 
 
 
Midstream clean void method 
 For both males and females, the mid stream clean voided or clean 
catch specimen is most often recommended. The method is non invasive 
and with good instruction yields an adequate specimen for microbiological 
examination. In females adequate periurethral washing before sampling 
results in fewer positive cultures. 
 
 In preparation for collection of a clean voided specimen, the patient 
is asked to wash hands dry. The female patient is instructed to clean the 
urethral meatus thoroughly after separate in labia. Keeping the labia spread 
she should begin to void. In males also the urethral meatus should be 
washed thoroughly after retracting the foreskin if he is uncircumcised and 
then void. The patent should discard the initial portion of urine about (15-
30 ml) in the toilet. Then aseptically a specimen of urine should be 
collected in a sterile container. 
 
Specimen transport: 
 The proper handling and transport of urinary specimens are crucial 
to obtaining reliable information. Specimens transported without a 
preservative must be cultured within 1–2 hours, or else cooled immediately 
at 4C. This refrigeration is necessary to prevent rapid logarithmic phase 
growth which can leads to spurious increase in CFU/ml. If refrigerated, 
specimens should be stored for not more than 24 hours. Refrigeration does 
not preserve WBCs very well. Frozen specimens are unacceptable for 
culture and should be rejected. The FLORASTAT URINE 
TRANSPORTING System is a newly developed lyophilized transport 
system that seems to be able to stabilize, microbial population for 24 hours 
at room temperature even in the presence of antibiotics
57
. 
 
Microbiology of UTI 
 E.Coli is the commonest cause of UTI and is found in about 90% of 
uncomplicated infections is general population and 50% of hospital 
acquired infection. Other primary pathogens include proteus mirabilis 
which is a common cause of UTI in boys and men and is associated with 
renal abnormalities particularly calculi. Proteus species may cause chronic 
UTI in association with obstruction or use of instruments. Streptococci are 
seldom primary pathogens and urinary tract enterococci are often found as 
contaminants in UTI. Group B streptococci appear to be occasional 
primary pathogen in women. Staph. Epidermidis and micrococci are part of 
normal skin flora and often found as contaminated in urine. The 
novobiocin resistant staph. Saprophyticus is a true primary pathogen of 
urinary tract. 
 
 In the complicated UTI that occur particularly in hospital patients, 
E.Coli is still the commonest causative organism. But other members of 
enterobacteriaceae such as klebsiella, enterobacter, indole positive proteus 
and citrobacter are also frequent. UTI due to streptococcus fecalis are 
usually associated with the use of instruments or catheterization. 
Pseudomonas aeruginosa infections associated with major structural or 
physiological abnormalities of urinary tract or permanent urethral 
catheterization. Staph. Aureus is uncommon and almost invariably 
associated with localized lesions of kidney or is secondary to 
prostatectomy or catheterization. The role of anaerobes and other fastidious 
bacteria is doubtful. 
 
Laboratory methods:             
 Examination of the urine will include microscopy, chemical 
examination and quantitative culture. The purpose of microscopy is to 
determine the numbers of white cells, but an increase (pyuria) does not 
necessarily indicate the presence of in inflammation. Pyuria is present in 
most clinical infections but may be absent in symptomless bacteriuria. 
Gross contamination of the urine with white cells may occur where there is 
a genital tract infection or urethritis. Urethral catheterization may increase 
the number of white cells in the urine. Pyuria without bacteriuria may be an 
indication of tuberculosis. The excretion of white cells is variable and 
results obtained on a single specimen of urine may be highly misleading. A 
better assessment is obtainable from a timed 4 or 6 hour excretion. 
Microscopy will also reveal the presence of urinary casts, red cells, renal 
tubular cells or atypical cells which may indicate non-infective renal 
pathology. White cells and bacteria seen in gram stained films of the 
urinary deposit may have come from the genital tract. 
 
Methods of detecting bacteriuria and pyuria 
Cultural * Quantitative   Pour-plate technique.  
     Surface viable count 
  * Semiquantitative Standard loop (streak) 
     Filter – paper method 
     Dip-spoon 
     Dip-slide 
     Agar-cup 
     Roller tube 
     Pad culture  
     Swab culture 
 
Chemical    Griess nitrate 
     Tetrazolium chloride (TTC) 
     Glucose oxidase    
     Catalase 
    
White Cells    Quantitative count 
     Leucocyte esterase 
Bacteria    Gram’s stain 
     Bac – T – Screen 
 
 
Automated    Photo metry (turbidity) 
     Bioluminescence (ATP assay) 
     Electrical impedance 
     Limulus – ameobocyte assay (endotoxin) 
     Micro calimetry (heat production) 
     Coulter counter (particle size) 
     Radiometry (BACTEC, Carbon 14) 
 Pour Plate Method: (Quantitative) 
 
 This method yields a quantitative culture of urine, in which serial 
dilutions of urine specimen are incorporate into 50C agars, which is then 
mixed and poured into plates. The medium is allowed to solidify and 
incubate at 35C for 24 hours. This time consuming process allows the 
enumeration of bacteria based on the dilution factor. 
 
Surface streak procedure (Semiquantitative): 
Semi quantitative cultures are carried out in a standardized fashion 
by using the surface streak procedure for delivering a measure volume of 
well mixed urine on to an agar surface. To ensure accuracy a vertically 
held calibrated loop must be dipped quickly and without specimen 
carryover on the shank. The calibrated loop is used to streak a straight line 
down the middle of the agar surface.  
 
The agar surface is then cross-stretched for isolated colonies. 
Inoculation with a 0.001 ml loop will permit detection of lower counts. To 
determine the member of CFU/ml in the original specimen the number of 
CFU detected after incubation is multiplied by 1000 if a 0.001 ml loop was 
used. 
  
Media used are a standard combination of a nonselective and 
selective agar for gram-negative bacilli. Agar plates are usually incubated 
at 35-37C under aerobic conditions in normal situations. Generally 18-24 
hrs incubations is sufficient, except for fastidious organisms and isolates 
from patients on antimicrobial therapy which require longer periods of 
incubation.  
  
Various techniques are available for determining the susceptibility of 
urinary pathogens to antimicrobial agents. Methods in general use are the 
Impregnated Disc, Break Point and Minimum Inhibitory Concentration 
Tests. 
 
 
Principles for treatment:    
 Asymptomatic patients usually do not require treatment since 
spontaneous remission is common. However pregnant woman, diabetics or 
patients for surgery and instrumentation require treatment due to the risk of 
serious complications. Antimicrobial therapy should be tailored to needs of 
the individual patient but two major principles must be followed. 
 
1. Dose of the antimicrobial agent should produce therapeutic 
concentration at the infection site. 
2. The course of treatment should be only as long as in necessary to 
achieve the defined effect, to minimize ill effects of bacterial 
resistance, superinfection and drug toxicity. 
 
In acute simple infections a three day short course is usually sufficient 
and acceptably to patients, especially in uncomplicated UTI. 
 
In complicated UTI which may show pathogens with resistance, a 
prolonged course and higher doses (particularly when renal involvement is 
present) are needed. 
 
 
 
 
 
S.No Treatment regimens Empirical Treatment 
1. 
Acute uncomplicated cystitis 
in women 
3 day regimen 
ORAL: Trimethoprim & 
sulfamethoxasons 160/800. q12 h 
quinolone or Norfloxacin 400 mg BD, 
Ofloxacin 200 mg BD.  
Diabetic, pregnant women 7 days. 
2. 
Acute uncomplicated 
pyelonephritis in women 
ORAL quinolone 7 -14 days. (or) 
Single dose Inj. ceftriaxone (1g), 
Gentamicin 3-5 mg/kg IV followed by 
ORAL, Trimethoprim – SMX 14 days 
3. 
Complicated UTI in men & 
women 
Mild – ORAL Quinolone for 10-14 
days 
Severe (Urosepsis) – Parenteral 
ampicillin + Gentamicin, Ceftriaxone, 
Imipenam /cilastatin then Oral 
quinolone or TMP/SMX for 10-21 
days. 
         
MATERIALS AND METHODS 
 
A total of fifty patients aged 15 – 65 years having chronic kidney 
disease of varying severity attending the Nephrology and Medicine 
departments in Thanjavur Medical College Hospital, Thanjavur were 
studied (group) with in a period of 1 year from December 2009 to 
November 2010. Based on estimated GFR, Chronic Kidney Disease of 
stage 3 to 5 are included in the study. Group B consists of 50 age and sex 
matched control which included those who came for master health check 
up and healthy bystanders of patients. 
 
Exclusion criteria: 
1. Patients having infection related renal disease such as chronic 
pyelonephritis. 
2. Diabetes mellitus 
3. Patients on immunosuppressive drugs. 
4. Indwelling or recent urinary catheterization 
5. Urinary tract obstruction (urethral stricture, prostatic enlargement 
renal or ureteric calculi) or ADPKD 
6. Patients on antimicrobials at the time of the study or within one 
week of the study. 
7. Patients with HIV infection. 
Detailed history was taken with particular emphasis on dysuria, 
urgency, frequency, abdominal pain, fever with chills, abdominal 
distension. Pedal edema and oliguria (oliguria refers to a 24 hours urine 
output of < 400 ml). Past history of hypertension and renal failure of more 
than 3 months were noted. 
 This was followed by detailed general examination. The presence of 
pallor, abdominal distension and pedal edema were looked for. The pulse, 
blood pressure and body weight were recorded and detailed systemic 
examination was carried out.  
 An elaborate laboratory examination of cases which included  
- Complete hemogram 
- Blood sugar 
- Blood urea 
- Serum creatinine 
- Serum electrolytes 
- USG abdomen62 
 The normal size of the kidneys are 10-13cm x 5-7cm. 
 In chronic kidney disease  
 Both kidneys are shrunken in size. 
 Hyper echoic cortex compared with liver 
 Cortical thickness is reduced 
 Cortico medullary differentiation (CMD) is lost.    
All the cases and controls were subjected to urine examination for 
albumin, sugar and leukocytes, as well as culture and antibiotic sensitivity 
testing. 
  
For microscopic examination of urine a clean catch urine sample was 
used. Urine specimen was examined within 1 – 3 hrs to avoid lysis of cells 
and casts. Centrifuged samples were used and leukocytes were counted 
under high power field and expressed as average number of leukocytes per 
HPF. 
 
 Urine culture was done by collecting mid stream clean catch urine 
specimen in autoclaved container. These were immediately plated on 
appropriate agars with graduated loops, incubated over night and 
examined. Results were expressed as colony forming unit (CFU) per ml of 
urine. All the bacterial isolates were identified by standard bacteriological 
techniques. Antibiotic susceptibility was also tested. 
 
 Symptomatic was defined as one having dysuria, frequency, 
urgency, abdominal pain associated with fever with chills and rigor. 
 
 
 Significant bacteriuria was defined as bacterial count greater than or 
equal to 10
5
 CFU/ml of urine on two consecutive specimens in 
asymptomatic individuals or on culture of  105 CFU/ml of urine 
accompanied by signs and symptoms of UTI. Contamination of urine was 
suspected if 3 or more micro organisms were grown simultaneously in 
culture.  
 
Significant pyuria was defined as > 8 – 10 WBC per HPF in 
centrifuged specimens. 
  
Urinary tract infection was defined as simultaneous presence of 
significant Pyuria and Bacteriuria. 
 
OBSERVATION AND RESULTS 
 
Table – 1 
AGE DISTRIBUTION 
 
AGE IN 
YEARS 
STUDY 
(GROUP A) 
CONTROL 
(GROUP B) 
PERCENTAGE OF UTI 
STUDY CONTROL 
15-24 3 4 - - 
25-34 5 4 20% - 
35-44 13 13 7.69% 7.69% 
45-54 17 17 17.6% - 
55-64 10 10 20% - 
 65 2 2 - - 
TOTAL 50 50 - - 
 
 
 
 
 
 
 
 TABLE II 
AVERAGE AGE OF UTI 
 
 
STUDY (GROUP A) 
CONTROL (GROUP 
B) 
MEAN AGE 45.22 Yrs. 45.4 Yrs. 
MEDIAN AGE 45.5 Yrs. 46 Yrs. 
% OF UTI IN YOUNG 
AGE GROUP 
(15-44 Yrs.) 
9.5% 4.76% 
% OF UTI IN OLD 
AGE GROUP (45-65 
Yrs.) 
17.2% - 
 
 
 
 
 
 
 
 
TABLE III 
SEX DISTRIBUTION 
 
AGE 
GROUP 
STUDY (GROUP A) CONTROL (GROUP B) 
MALE FEMALE MALE FEMALE 
15-24 Yrs 1 2 3 1 
25-34 Yrs 2 3 3 1 
35 -44 Yrs 8 5 7 6 
45-54 Yrs 11 6 11 6 
55-64 Yrs 8 2 6 4 
 65 Yrs 2 - 1 1 
TOTAL 32 18 31 19 
 
 
 
 
 
 
 
 
 
TABLE IV 
% OF UTI ACCORDING TO SEX DISTRIBUTION 
 
AGE 
GROUP 
PERCENTAGE OF UTI 
STUDY (GROUP A) STUDY (GROUP B) 
MALE 
%/(n) 
FEMALE 
%/(n) 
MALE 
%/(n) 
FEMALE 
%/(n) 
15-24 Yrs - - - - 
25-34 Yrs - 33.3% (1) - - 
35-44 Yrs 12.4% (1) - - 16.6% (1) 
45-54 Yrs 18.18% (2) 16.6% (1) - - 
55-64 Yrs 25% (2) - - - 
 65 Yrs - - - - 
TOTAL 15.6% 11.11% - 5.2% 
 
 
 
 
 
 
 
TABLE V 
CORRELATION BETWEEN SIGNIFICANT BACTERIURIA AND 
PYURIA WITH UTI, IN CKD AND CONTROL GROUPS 
 
IN STUDY GROUP A 
 
AGE 
GROUP 
NUMBER 
OF 
PATIENTS 
SIGN. 
BACTERIURIA 
(n/%) 
SIGN. 
PYURIA 
(n/%) 
UTI 
(n/%) 
SYMPT. 
UTI 
ASYMPT 
UTI 
15-44 
Yrs 
21 3 (14.25%) 
3 
(14.28%) 
2 
(9.5%) 
1 (20%) 1 (5.5%) 
45-65 
Yrs 
29 9 (31.03%) 
5 
(17.24%) 
5 
(17.2%) 
3 
(27.2%) 
2 (12.5%) 
TOTAL 50 12 (24%) 8 (16%) 7 (14%) 4 (25%) 3 (8.8%) 
 
  
 
TABLE VI 
IN CONTROL GROUP B 
 
AGE 
GROUP 
NUMBER OF 
PATIENTS 
SIGN. 
BACTERIURIA 
(n/%) 
SIGN. 
PYURIA 
(n/%) 
UTI (n/%) 
SYMPT. 
UTI 
ASYMPT 
UTI 
15-44 
Yrs 
21 1 (4.76%) 1 (4.76%) 
1 
(4.76%) 
1 
- 
45-65 
Yrs 
29 1 (3.44%) - - - 
- 
TOTAL 50 2 (4%) 1 (2%) 1 (2%) 
1 
(33.3%) 
- 
 
 
 
 
 
 
 
 
 
 TABLE VII 
UTI IN RELATION TO CKD IN TERMS OF SEVERITY 
 
 
CHRONIC KIDNEY DISEASE 
STAGE III 
GFR 30 – 59 
STAGE IV 
GFT 15 – 29 
STAGE V 
GFR < 15 
Number of 
Patients 
(n / %) 
7 (14%) 29 (58%) 14 (28%) 
(n / %) UTI - 2 (6.89%) 5 (35.71%) 
 
Chi square – X2 5.75  P value < 0.01     
 
 
 
 
 
 
 
 
 
 TABLE VIII 
UROPATHOGENS IDENTIFIED IN CKD PATIENTS 
 
ORGANISM 
NO.OF 
CASES/ 
% 
SIGN. 
PYURIA 
SIGN. 
BACTERIURIA 
UTI 
(n/%) 
E.Coli 11 (22%) 7 9 6 (12%) 
Klebsiella 3 (6%) - 2 - 
Pseudomonas 1 (2%) 1 1 1 (2%) 
Proteus 1 (2%) - - - 
Enterococcus - - - - 
Staphylococcus - - - - 
TOTAL 16 (32%) 8 (16%) 12 (24%) 7 (14%) 
 
 
 
 
 
 
 
ANALYSIS AND DISCUSSION 
 
AGE AND SEX DISTRIBUTION OF UTI 
       The age of the patients varied from 15 to 65 years in the study. 
The means age of group A CKD was 45.22 yrs and the median age was 
45.5 yrs. The study group comprised 32 males and 18 females (64 
percentage and 36 percentage respectively). 
 
  In comparison the group B (control) consisted 50 age and sex 
matched persons, comprising 31 males and 19 females (62% and 38% 
respectively) The mean age of this group was 45.4 yrs and the median age 
was 46 yrs. 
 
  Among CKD patients the incidence of UTI in the older age group 
45 to 65 yrs was higher (17.2%) compared to the younger population 
between 15 to 45 yrs (9.5%). On comparing the incidence of UTI in the 
two sexes in CKD group, the incidence was (15.6%) in males and (11.1%) 
in females.  
 
  Amongst the controls none of the 31 males had UTI while (5.2%) 
of females had UTI. In our study males had more UTI than females in 
CKD whereas in control group females were more affected.  In a study by 
Gauba et al (1997)
2
 males with CKD had higher incidence (14.2%) than 
females (8.1%).  
 
SYMPTOMATOLOGY 
Of the 50 patients in Group A 16 patients (32%) presented with 
symptoms of UTI. Most common symptoms were dysuria, increased 
frequency, urgency of micturition and lower abdominal pain. Among the 
CKD patients having symptoms suggestive of UTI, 25% were found to 
have UTI whereas among the asymptomatic patients 8.8% had UTI. Of the 
control with symptoms of UTI, 33.3% had UTI while none of the 
asymptomatic persons had UTI. 
 
  In our study, the CKD group showed a higher incidence of 
asymptomatic infection as opposed to control group, where only 
symptomatic infection was observed. Choudhry et al (1993)
58
 suggested 
that patients with end stage renal disease with their defective host defence 
mechanism and those with low urine volume and urine stasis are at higher 
risk of asymptomatic UTI. 
 
SIGNIFICANT BACTERIURIA AND PYURIA 
  The incidence of significant pyuria (8-10 pus cells /HPF) was 16% 
in patients with CKD whereas significant bacteriuria and UTI were (24%) 
and (14%) respectively. In comparison, among the control subjects the 
incidence of significant pyuria was (2%), significant bacteriuria and UTI 
were (4%) and (2%) respectively.  
   
In a study by (Montogomerire et al )
48
  60% that is 49/81 patients 
with CKD developed various infection. In these patients if chronic 
pyelonephritis was excluded, 44% had UTI which was exceeded only by 
pulmonary infections. In a study by Annemurray et al there was 2-3 fold 
increased risk of sepsis, UTI and pneumonia in patients with CKD
47
. 
 
  Saitosh et al
58
 reported an incidence of 27% of bacteriuria 38% of 
pyuria and 19% UTI in 182 oliguric patients with CKD. Collins AJ United 
States renal data system
59
 also supports this. Mehr and associates
61
 reported 
the 27 of the 62 patients (44%) had bacteriuria and / or innumerable 
leukocytes in the urine sediments.  
 
  The incidence of UTI among CKD patients is 14% and 2% in 
Control population. The difference in proportion is significant (P< 0.05; 
Z = 2.27). 
 
  The proportion of bacteriuria among CKD patients is 24% and 
among control is 4%. The difference in proportion is highly significant 
(P<0.001: Z= 3.009) 
    The proportion of pyuria among CKD patients is 16% and among 
control group is 2%. The difference is significant (P<0.05: Z=2.54) 
 
SEVERITY OF CKD AND UTI 
 
  The incidence of UTI increased with severity of CKD. It was found 
that incidence of UTI in stage 4 and stage 5 were 6.89% and 35.71% 
respectively, where as in stage3 there was no positive case for UTI. The 
incidence of UTI is increased with the severity of CKD significantly. 
CHI square X2 5.75,  P < 0.01. 
 
  In the study by Gauba et al 
2
 they found that in patients with mild 
and moderate CKD the incidence of UTI was 6.6% and 8.7% respectively, 
where as 47% of the patients with severe CKD had evidence of UTI. 
 
  Similarly the daily urine output also appeared to have an influence 
on the incidence of UTI. The incidence of infection with urine output of 
400ml or less per day had (3.14%) incidence of UTI. Friedman and 
Gladstone(60) reported the effects of hydration and bladder incubation 
time on urine colony count. Fault reported that confirmation of the 
diagnosis of UTI raised obvious difficulties in patients with little or no 
urine output. He stated that patients whose urine output is only a few ml 
per day capable of producing a clean catch sample for culture as also that a 
single voided samples are enough for diagnosis in patients whose urine 
output was only few ml per day.  
 
  According to (saitosh et al 
58
 ) pyuria is associated with decreased 
urine output and was frequent in oliguric patients. 
 
  In our study, among 21 oliguric patients 7 showed significant 
pyuria(33.3%) and 11 showed significant bacteriuria (52.3%). In 
nonoliguric patients the incidence of both significant bacteriuria and pyuria 
was (3.47%).  
 
UROPATHOGENS 
  In the present study gram negative organisms were identified most 
frequently. E.Coli was the most prevalent organism and it contributed 
85.7% as the causative organism of UTI in CKD patients, followed by 
pseudomonas (14.35%) 
 
  In the study by us 16 positive urine culture was obtained from the 
CKD group of which 11 was by E.Coli (68.75%), 3 by Klebsiella 
(18.75%), I by proteus and pseudomonas each (6.25%% each). According 
to study by saitosh et al
59
 E.Coli Pseudomonas and Klebsiella contributed 
40%, 10% and 12% respectively as causative organisms of UTI in CKD 
patients. They got 50 positive urine culture out of 184 patients of which 
40% was by E.Coli 10% by pseudomonas, 12% by Klebsiella and 30% by 
enterococcus. Gauba et al
2
 in his studies obtained gram negative organisms 
in the majority (83.3%) of patients with UTI in CKD. E.Coli was the most 
prevalent organism and caused UTI in about 50% of cases, followed by 
Klebsiella (16.6%) and Pseudomonas (8.3%). 
 
Among the 50 controls in our study one had UTI. Among the 31 
males none had UTI while one out of 19 females had UTI E.Coli was the 
organism identified. 
 
    The ratio between incidence of UTI among patients with CKD and 
incidence of UTI among control population is 7 (relative risk). Hence the 
patients with CKD seven times more prone to develop UTI when 
compared to normal population.  
CONCLUSION 
 
1. THE INCIDENCE OF UTI AMONG CKD PATIENTS AT 
THANJAVUR MEDICAL COLLEGE, THANJAVUR WAS 
FOUND TO BE 14/100 PATIENTS (ONE IN SEVEN 
PATIENTS). 
2. THE INCIDENCE OF UTI IN GENERAL POPULATION 
WAS 2/100 POPULATION (ONE IN FIFTY PATIENTS). 
3. UTI WAS MORE FREQUENT IN THE OLDER AGE GROUP 
THAN YOUNGER IN CKD. 
4. AMONG THE GENERAL POPULATION, UTI WAS MORE 
FREQUENT IN YOUNGER AGE GROUP. 
5. FEMALES OF GENERAL POPULATION WERE MORE 
AFFECTED WITH UTI. 
6. ASYMPTOMATIC UTI WAS MORE COMMON IN CKD 
PATIENTS. 
7. THE COMMON PRESENTING SYMPTOMS WERE 
DYSURIA, URGENCY, FREQUENCY OF MICTURITION 
AND LOWER ABDOMINAL PAIN. 
8. SIGNIFICANT PYURIA AND BACTERIURIA WERE MORE 
PREVALENT IN THE CKD PATIENTS THAN IN GENERAL 
POPULATION. 
9. A HIGHER INCIDENCE OF UTI WAS FOUND AS THE 
SEVERITY OF CKD INCREASES. 
10. UTI IS MORE PREVALENT IN OLIGURIC CKD PATIENTS 
THAN THE NONOLIGURIC PATIENTS. 
11. GRAM NEGATIVE ORGANISMS WERE THE COMMON 
ISOLATES IN URINE CULTURES. 
12. E.COLI WAS FOUND AS THE COMMONEST CAUSATIVE 
OF UTI IN CKD AS WELL AS IN GENERAL POPULATION. 
13. PSEUDOMONAS WAS THE SECOND COMMONEST 
CAUSATIVE AGENT OF UTI IN CKD. 
14. E.COLI WAS ALSO THE COMMONEST ORGANISM 
IDENTIFIED IN THE POSITIVE URINE CULTURES 
FOLLOWED BY KLEBSIELLA, PROTEUS AND 
PSEUDOMONAS. 
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UTI IN RELATION TO CKD IN TERMS OF SEVERITY 
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PREVALENCE OF UTI IN CKD PATIENTS 
PROFORMA 
 
Name   Age   Sex   Body Weight (Kg) 
OP/IP NO  Ward/op  DOA 
      DOD 
 
PRESENT ILLNESS: 
 
H/O Dysuria        Yes/No 
H/O Frequency        Yes/No 
H/O Urgency        Yes/No 
H/O Fever        Yes/No 
H/O Chills / Rigor       Yes/No 
H/O Flank Pain        Yes/No 
H/O Abd. Distension       Yes/No 
H/O Oliguria        Yes/No 
H/O Recent Urinary Catheterization      Yes/No 
H/O Immuno Suppressive Drugs     Yes/No 
 
PAST HISTORY: 
 
   HT 
   DM 
   URETERIC COLIC 
   CKD: Duration :  on PD / HD 
 
TREATMENT HISTORY: 
   On antibiotics- Yes/No 
   Details: 
EXAMINATION: 
 
 Pallor:   Edema:   Pulse: 
       BP: 
 
CVS   : 
RS   : 
ABDOMEN  : 
CNS   : 
 
INVESTIGATION: 
 Hb% 
 Tc: 
 Dc: 
 Blood urea: 
 Sr. Creatinine: 
 Blood Sugar: 
 Sr. Sodium: 
 Sr. Potassium: 
 HIV I & II: 
GFR (Cock Craft & Gault formula)  
 
USG ABDOMEN: RK:  LK:  CMD:   Echotexture: 
  Bladder: 
URINE: 
Albumin:  Sugar:   Deposit:  Significant Pyuria: 
 
CULTURE & SENSITIVITY: 
 
 Organism  : 
 Colony count  : 
 Significant bacteriuria : 
 Highly sensitive to :   
 
 
